A unique technology to rapidly screen new drugs, therapies

drug
Credit: CC0 Public Domain

The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.

The technology, made possible by a gift to the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, could cut the screening time for new drug therapies by half. That means therapies and pharmaceuticals could be ready for patients faster than ever before.

“This technology does not exist at any academic institution in the Mountain West and is limited between the two coasts, placing the CU Anschutz Medical Campus in a unique position to advance drug discovery in Colorado and beyond,” said David Ross, Ph.D., associate dean for research at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. “We envision this new screening and imaging technology will be applied to both small molecule and biologic drug development

Read More
Read More

CU Anschutz announces unique technology to rapidly screen new drugs, therapies

The University of Colorado Anschutz Medical Campus announced a new robotic screening and imaging technology today marking a major breakthrough in the detection and treatment of disease.

The technology, made possible by a gift to the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, could cut the screening time for new drug therapies by half. That means therapies and pharmaceuticals could be ready for patients faster than ever before.

“This technology does not exist at any academic institution in the Mountain West and is limited between the two coasts, placing the CU Anschutz Medical Campus in a unique position to advance drug discovery in Colorado and beyond,” said David Ross, PhD, associate dean for research at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. “We envision this new screening and imaging technology will be applied to both small molecule and biologic drug development and will position the

Read More
Read More

A Bet on Europe Is a Bet on Drugs, Against Tech

The skew toward tech giants in the U.S. stock market is well known. Less appreciated is that Europe’s markets are now dominated by drugmakers.

Healthcare accounts for a quarter of the Stoxx Europe 50 index—almost as much as the almost 28% represented by information technology in the S&P 500. Five of Europe’s top 10 companies by market value are now drug producers:

Novartis,

Roche,

AstraZeneca,

Sanofi

and Denmark’s

Novo Nordisk.

This trend isn’t new, but it has been turbocharged by this year’s pandemic-driven downturn, which has highlighted the social relevance of the drug industry as well as its typically recession-proof profit profile. A vaccine AstraZeneca has licensed from the University of Oxford is a front-runner in the battle against Covid-19.

The rise of health care is one result to emerge from an analysis of Europe’s largest companies and how they have shifted over the past decade and

Read More
Read More

Influenza Drugs Market 2020 Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global Forecast To 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 24, 2020 (The Expresswire) —
Global “”Influenza Drugs Market“”(2020-2026) status and position of worldwide and key regions, with perspectives of manufacturers, regions, product types and end industries; this report analyses the topmost companies in worldwide and main regions, and splits the Influenza Drugs market by product type and applications/end industries.The Influenza Drugs market trend research process includes the analysis of different factors affecting the industry, with the government policy, competitive landscape, historical data, market environment, present trends in the market, upcoming technologies,technological innovation, and the technical progress in related industry, and market risks, market barriers,opportunities, and challenges.

Get a sample PDF of the report at-https://www.360researchreports.com/enquiry/request-sample/16172948

The global Influenza Drugs market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at

Read More
Read More

These molecular insights may foster effective therapies using existing drugs for patients with COVID-19 — ScienceDaily

Viral and bacterial pathogens wield pathogenic or virulent proteins that interact with high-value targets inside human cells, attacking what is known as the host interactome. The host interactome is the network map of all the protein-protein interactions inside cells.

Such networks have been studied in organisms as diverse as plants, humans and roundworms, and they show a similarity to social networks like Facebook or airline route maps. In Facebook, a few people will have a huge number of friend connections, some will have many, and a vast majority will have much fewer. Similarly, airlines have a few hubs that many passengers pass through on the way to their destinations.

Host interactomes show a limited number of high-powered hubs — where a protein has a large number of connections — and a limited number of important bottlenecks, which are sites with a large number of short paths to a node. These

Read More
Read More